• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
Pharmaceutical Benefits Scheme updates to start 2020

Pharmaceutical Benefits Scheme updates to start 2020

The safety net threshold has been lowered, while a new drug that provides a treatment option for patients with advanced breast cancer has been added.


GP poll: Iron infusions in general practice

GP poll: Iron infusions in general practice

Would appropriate remuneration encourage you to offer this service more often?


Australian GP named in global list of elite researchers

Australian GP named in global list of elite researchers

Professor Paul Glasziou has been recognised as one of the world’s most cited researchers in 2019.


People experiencing psoriasis and asthma receive PBS relief

People experiencing psoriasis and asthma receive PBS relief

Patients with urea cycle disorder will also benefit from the new round of listings.


Australian drug prices low by world standards

Australian drug prices low by world standards

A new report has found Australians are paying among the lowest prices in the world for generic prescription drugs.


Cystic fibrosis drug listed on PBS

Cystic fibrosis drug listed on PBS

While the announcement was welcomed, some have questioned the seven month delay between approval and listing.


Pharmaceutical Benefits Advisory Council responds to criticism

Pharmaceutical Benefits Advisory Council responds to criticism

Chair Andrew Wilson said suggestions of delayed approvals are not new and Australia has one of ‘the fastest systems in the world’.


Cancer and inflammatory disease medicines receive $56 million boost

Cancer and inflammatory disease medicines receive $56 million boost

Four new medicines will be listed through the Pharmaceutical Benefits Scheme, helping patients fight aggressive cancers and inflammatory conditions.


Access to cystic fibrosis medication expanded

Access to cystic fibrosis medication expanded

Children aged 12–24 months with a rare form of the genetic disorder will soon be eligible to receive subsidised medication, saving their families up to $300,000 per year.


Behind the scenes at the PBAC

Behind the scenes at the PBAC

Outgoing RACGP representative Rashmi Sharma pulls back the curtain after 10 years on the Pharmaceutical Benefits Advisory Committee.


  • Previous
  • ...
  • 4
  • 5
  • 6
  • ...
  • Next
Pages: 5 of 7
RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807